Cite

HARVARD Citation

    Plevris, N. et al. (2019). Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission. Inflammatory bowel diseases. 25 (6), pp. 1036-1043. [Online]. 
  
Back to record